Size: 5 mg / 10 mg / 15 mg / 30 mg
Tirzepatide represents a dual "twincretin" class of metabolic regulators. Pairing GIP receptor agonism with GLP-1 activity yields greater weight loss and blood glucose control than selective GLP-1 receptor agonists alone.
Supply duration: 12 to 52 weeks continuous administration
Simultaneously activates endogenous GIP and GLP-1 receptors. GIP receptor activation enhances adipose tissue lipid clearance and metabolic flexibility, while GLP-1 activation slows gastric emptying, increases central satiety, and drives glucose-dependent insulin release.
PURITY CHECK
HPLC Chromatogram provided with every shipment.
ZERO FILLERS
Free of residual solvents, heavy metals, or unlisted buffers.
SECURE DELIVERY
Discreet, protective thermal packaging.
It activates both GIP and GLP-1 incretin hormone receptor pathways simultaneously.
You can feel it in your focus, your recovery, and your daily rhythm.
Three simple steps for a desired outcome
Proper storage and handling of laboratory reagents in vial format is crucial for ensuring their effectiveness and reliability. To maintain their integrity, it's important to follow specific guidelines for temperature control, light exposure, and contamination prevention.
